Celldex’s METRIC Study in Metastatic Triple-negative Breast Cancer Does Not Meet Primary Endpoint Genetics Investing
NewLink Genetics Announces Initial Phase 1 Data with Indoximod Plus Radiation and Chemotherapy for Pediatric Patients Genetics Investing
Loxo Oncology and Illumina to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics Genetics Investing
AGTC Announces Completion of Enrollment of Phase 1 / 2 Clinical Study of Investigational Gene Therapy Genetics Investing
Data Monitoring Committee Completes Planned Safety and Data Review of Celsion’s Phase III OPTIMA Study Pharmaceutical Investing